Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

被引:0
|
作者
Canavesi, Giada [1 ]
Mena, Maurizio [1 ]
Zaninetta, Elena [2 ,3 ]
Gazzola, Lidia [2 ,3 ]
Bini, Teresa [2 ,3 ]
Orofino, Giancarlo [4 ,5 ]
De Vito, Andrea [6 ,7 ]
Madeddu, Giordano [6 ,7 ]
Grillo, Chiara [8 ,9 ]
Bartalucci, Claudia [10 ,11 ]
Centorrino, Federica [10 ,11 ]
Squillace, Nicola [12 ,13 ]
Bonfanti, Paolo [12 ,13 ]
Tiecco, Giorgio [14 ,15 ]
Foca, Emanuele [14 ,15 ]
Menozzi, Marianna [16 ,17 ]
Guaraldi, Giovanni [16 ,17 ]
Bana, Nicolas Brian [18 ]
Cavazza, Giovanni [18 ]
Rossotti, Roberto [18 ]
Lo Caputo, Sergio [8 ,9 ]
Di Biagio, Antonio [10 ,11 ]
Rusconi, Stefano [1 ]
机构
[1] Osped Nuovo Legnano, Infect Dis Unit, ASST Ovest Milanese, Legnano, Italy
[2] San Paolo Hosp, Infect Dis Unit, ASST Santi Paolo & Carlo, Milan, Italy
[3] Dipartimento Sci Salute, Milan, Italy
[4] Amedeo Savoia Hosp, Infect Dis Unit, Turin, Italy
[5] Univ Turin, Turin, Italy
[6] Azienda Osped Univ Sassari, Infect Dis Unit, Sassari, Italy
[7] Univ Sassari, Sassari, Italy
[8] Azienda Osped Univ Osped Riuniti Foggia, Infect Dis Unit, Foggia, Italy
[9] Univ Foggia, Foggia, Italy
[10] Osped Policlin San Martino, Infect Dis Unit, Genoa, Italy
[11] Univ Genoa, Genoa, Italy
[12] IRCCS San Gerardo Tintori, Infect Dis Unit, Monza, Italy
[13] Univ Milano Bicocca, Monza, Italy
[14] Spedali Civili Brescia, Infect Dis Unit, Brescia, Italy
[15] Univ Brescia, Brescia, Italy
[16] Azienda Osped Univ Modena, Infect Dis Unit, Modena, Italy
[17] Univ Modena & Reggio Emilia, Modena, Italy
[18] ASST Grande Osped Metropolitano Niguarda, Infect Dis Unit, Milan, Italy
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P074
引用
收藏
页码:86 / 88
页数:3
相关论文
共 50 条
  • [21] Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy
    Atoyebi, Shakir
    Bunglawala, Fazila
    Cottura, Nicolas
    Granana-Castillo, Sandra
    Montanha, Maiara Camotti
    Olagunju, Adeniyi
    Siccardi, Marco
    Waitt, Catriona
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [22] Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort
    De Vito, Andrea
    Botta, Annarita
    Berruti, Marco
    Castelli, Valeria
    Lai, Vincenzo
    Cassol, Chiara
    Lanari, Alessandro
    Stella, Giulia
    Shallvari, Adrian
    Bezenchek, Antonia
    Di Biagio, Antonio
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [23] Expanded Insights From a Case Study on Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnancy
    Ziemba, Lauren
    Ketchum, Rachel
    Brummel, Sean
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [24] Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis
    van Welzen, Berend J.
    Van Lelyveld, Steven F. L.
    Ter Beest, Gerjanne
    Gisolf, Jet H.
    Geerlings, Suzanne E.
    Prins, Jan M.
    Van Twillert, Gitte
    Van Nieuwkoop, Cees
    Van der Valk, Marc
    Burger, David
    Wensing, Annemarie M. J.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 189 - 195
  • [25] Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine
    Alagaratnam, Jasmini
    Kelly, Niall
    Dustan, Simon
    Naous, Nadia
    Nwanbila, Modest
    Byrne, Ruth
    Girometti, Nicolo
    Asboe, David
    Taylor, Graham P.
    Boffito, Marta
    AIDS, 2025, 39 (01) : 95 - 98
  • [26] Real-life effectiveness, safety and acceptance of long-acting cabotegravir-rilpivirine: results from a large single-centre cohort
    Gonzalez-Cordon, Ana
    Laguno, Montserrat
    Berrocal, Leire
    Martinez-Rebollar, Maria
    Torres, Berta
    Chivite, Ivan
    Inciarte, Alexy
    Arreba, Paula
    Ambrosioni, Juan
    Foncillas, Alberto
    de la Mora, Lorena
    Luis Blanco-Arevalo, Jose
    Calvo, Julia
    Martinez, Esteban
    Sempere, Abiu
    Miro, Jose M.
    Llobet, Roger
    de lazzari, Elisa
    Mallolas, Josep
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 88 - 89
  • [27] Causes of discontinuation of long-acting cabotegravir and rilpivirine in clinical practice: results from the prospective multicentre SCOLTA cohort
    Taramasso, Lucia
    Squillace, Nicola
    Ricci, Elena
    Ferrara, Sergio
    Orofino, Giancarlo
    Sarchi, Eleonora
    Pontali, Emanuele
    Cenderello, Giovanni
    Pellicano, Giovanni Francesco
    Lagi, Filippo
    Salomoni, Elena
    Bargiacchi, Olivia
    Carleo, Maria Aurora
    Pusterla, Luigi
    Martini, Salvatore
    Bellagamba, Rita
    Madeddu, Giordano
    De Socio, Giuseppe Vittorio
    Menzaghi, Barbara
    Angioni, Goffredo
    Falasca, Katia
    Cascio, Antonio
    Di Biagio, Antonio
    Bonfanti, Paolo
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 76 - 78
  • [28] Early adopters of long-acting injectable cabotegravir/rilpivirine: what lessons can we learn?
    Wood, Brian R.
    Kumarasamy, Nagalingeswaran
    AIDS, 2024, 38 (03) : 425 - 426
  • [29] Comparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable Cabotegravir/Rilpivirine
    Kirk, Stephanie E.
    Young, Christina
    Berry, Hayley
    Hanson, Rochelle
    Moreland, Angela
    Fonner, Virginia
    Gebregziabher, Mulugeta
    Williams, Jamila
    Meissner, Eric G.
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [30] Efficacy and safety of long-acting intramuscular cabotegravir and rilpivirine in women: a substudy of the RELATIVITY cohort
    Galindo Puerto, Maria Jose
    Cabello Clotet, Noemi
    Aldamiz-Echevarria Lois, Teresa
    Llenas-Garcia, Jara
    Mar Arcos, Mari
    Troya, Jesus
    Buzon Martin, Luis
    Torralba, Miguel
    Santacreu, Mireia
    Aguilera Garcia, Maria
    Cabello Ubeda, Alfonso
    Crusells-Canales, Maria Jose
    Morano, Luis
    Pedrero Tome, Roberto
    Martin Rico, Patricia
    Montero Hernandez, Carmen
    Perez Martinez, Desiree
    de la Fuente Moral, Sara
    Calderon Hernaiz, Ruth
    Bernal, Enrique
    Vivancos Gallego, Maria Jesus
    Antonia Sepulveda, Maria
    Cecilio, Alvaro
    Arenas Garcia, Victor
    Padilla, Sergio
    Losa Garcia, Juan Emilio
    de las Revillas Almajano, Francisco Arnaiz
    Sanchez Guirao, Antonio Jesus
    Garcia Navarro, Maria Del Mar
    Cerezales Calvino, Ana
    Garcinuno Jimenez, Maria Angeles
    Ferreira Pasos, Eva Maria
    Estebanez, Miriam
    De la Calle Riaguas, Beatriz
    Egido Murciano, Miguel
    Ramos Vicente, Noemi
    Clavero Olmos, Marta
    Manuel Tiraboschi, Juan
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 75 - 76